Well, it won't get funded by a company unless there's a profit incentive, however there's other funding avenues for clinical trials like this. Besides applying for grants (which is extremely slow and extremely time consuming), research institutions often have small amounts of funds for running a trial in house, especially for something like this which only involves a few gene tests and an inexpensive treatment.

This. Article ends with: > But Cantley says it may be possible to make an oral formulation that reaches high doses in the blood—which may be one way to get companies interested in sponsoring trials.